Jingkai Wang

Key Laboratory Of Structure Based Drug Design And Discovery, 103 Wenhua Road, 110016, PR China
Shenhe District, Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Central Nervous System Targeting Nanovesicles for Trans-Barrier Delivery and Spinal Cord Injury Treatment.

Central Nervous System Targeting Nanovesicles for Trans-Barrier Delivery and Spinal Cord Injury Treatment.

Journal: ACS nano

Published: December 19, 2025

In situ carbon-induced electronic regulation of CuCo2O4 for significantly enhanced water-resistant DeNOX.

In situ carbon-induced electronic regulation of CuCo2O4 for significantly enhanced water-resistant DeNOX.

Journal: Journal of hazardous materials

Published: December 18, 2025

Controlled extracellular vesicles release from aminoguanidine nanoparticle-loaded polylysine hydrogel for synergistic treatment of spinal cord injury.

Controlled extracellular vesicles release from aminoguanidine nanoparticle-loaded polylysine hydrogel for synergistic treatment of spinal cord injury.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 13, 2023

Stain-free Gram staining classification of pathogens via single-cell Raman spectroscopy combined with machine learning.

Stain-free Gram staining classification of pathogens via single-cell Raman spectroscopy combined with machine learning.

Journal: Analytical methods : advancing methods and applications

Published: October 05, 2022

Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor.

Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor.

Journal: European journal of medicinal chemistry

Published: July 26, 2022

Identification of novel and potent PROTACs targeting FAK for non-small cell lung cancer: Design, synthesis, and biological study.

Identification of novel and potent PROTACs targeting FAK for non-small cell lung cancer: Design, synthesis, and biological study.

Journal: European journal of medicinal chemistry

Published: March 07, 2022

Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer.

Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer.

Journal: European journal of medicinal chemistry

Published: February 17, 2022

Enhancement of nucleus pulposus repair by glycoengineered adipose-derived mesenchymal cells.

Enhancement of nucleus pulposus repair by glycoengineered adipose-derived mesenchymal cells.

Journal: Biomaterials

Published: April 14, 2021

Injectable kartogenin and apocynin loaded micelle enhances the alleviation of intervertebral disc degeneration by adipose-derived stem cell.

Injectable kartogenin and apocynin loaded micelle enhances the alleviation of intervertebral disc degeneration by adipose-derived stem cell.

Journal: Bioactive materials

Published: November 03, 2020

A bioactive injectable self-healing anti-inflammatory hydrogel with ultralong extracellular vesicles release synergistically enhances motor functional recovery of spinal cord injury.

A bioactive injectable self-healing anti-inflammatory hydrogel with ultralong extracellular vesicles release synergistically enhances motor functional recovery of spinal cord injury.

Journal: Bioactive materials

Published: October 19, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026